Experts Advising FDA Vote Against Pfizer COVID Booster

Posted by on September 17, 2021 3:45 pm
Categories: US National Stories

A health care worker prepares Pfizer-BioNTech Covid-19 vaccines for third doses at a senior living facility in Worcester, Penn., in late August.

A panel of advisers to the Food and Drug Administration voted against a booster dose of the Pfizer-BioNTech COVID-19 vaccine be licensed for people 16 years and older.

(Image credit: Bloomberg/Bloomberg via Getty Images)

Leave a Reply

Your email address will not be published.